Navigation Links
AAIPharma Announces Promotion Of Dean Shirazi To EVP Of Analytical Laboratories
Date:12/12/2012

WILMINGTON, N.C., Dec. 12, 2012 /PRNewswire/ -- AAIPharma Services Corp. ("AAIPharma"), a leading provider of pharmaceutical product development services, announced today that it has promoted Dean Shirazi, Ph.D. to executive vice president of analytical laboratories.

(Logo: http://photos.prnewswire.com/prnh/20121207/MM26042LOGO)  

During his 20 year career at AAIPharma, Dr. Shirazi has helped AAIPharma excel in analytical chemistry and product development, most recently as vice president of analytical development.  With over 50 publications in scientific journals and a reference book in chromatography ("Fundamentals of Preparative and Nonlinear Chromatography, Second Edition"), Dr. Shirazi is a recognized expert in multiple types of liquid chromatography and gas chromatography.  Throughout his tenure, he has hired and trained a significant portion of laboratory personnel at AAIPharma, helping AAIPharma establish its leadership position in analytical chemistry and drug development.  In his new role, Dr. Shirazi will have responsibilities over the Wilmington and Durham analytical laboratories.   

"At AAIPharma, it has been an honor to work with thousands of clients throughout the industry," said Dr. Shirazi.  "My team and I look forward to continuing to help clients with their unique analytical challenges."

"The tenured analytical teams have long been the cornerstone of AAIPharma," said Patrick Walsh, Chief Executive Officer.  "As we continue to add new analytical capabilities in our new Wilmington Technology Center, Dr. Shirazi's analytical and regulatory expertise continues to be instrumental in coordinating our growth strategy."

Dr. Shirazi received his doctorate in analytical chemistry from Georgetown University. He conducted post-doctoral research at the University of Tennessee as a research associate, and his areas of interest are high performance liquid chromatography (HPLC), gas chromatography (GC), preparative chromatography, chiral separation and optimization of experimental conditions in chromatography.

About AAIPharma Services Corp. 

AAIPharma Services Corp. is a leading provider of contract services that support all phases of drug development. The company's wide array of capabilities includes analytical chemistry, formulation development, material testing services, microbiology, clinical and commercial contract manufacturing, pharmaceutical packaging and stability services. Serving more than 600 clients around the globe and headquartered in Wilmington, N.C., AAIPharma is a portfolio company of Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care.

For more information on the company, visit:
http://www.aaipharma.com.

For more information about our analytical development services, visit:
http://aaipharma.com/development/analytical-development

For more information about our analytical testing services, visit:
http://aaipharma.com/analytical-testing/

 


'/>"/>
SOURCE AAIPharma Services Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AAIPharma Appoints Senior Director of Biopharmaceutical Development
2. AAIPharma Appoints Director Of Analytical Chemistry
3. Alere Inc. Announces Hiring of Namal Nawana as Chief Operating Officer
4. Northwest Biotherapeutics, Inc. Announces Full Exercise of Over- Allotment Option
5. Cadence Pharmaceuticals Announces Termination of Option Agreement to Acquire Incline Therapeutics, Inc.
6. River Vision Announces Completion of $17 million Series A Financing
7. Winner Medical Announces Closing of Going Private Transaction
8. Alere Inc. Announces Early Results of its Tender Offer and Consent Solicitation for Any and All of its 7.875% Senior Notes due 2016
9. IDEXX Laboratories Announces Entry Into Consent Agreement with FTC Bureau of Competition Staff
10. Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
11. Net Medical Xpress Announces Substantial Teleradiology Growth and Major New Opportunities in Diagnostic/Clinical Crossover Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/11/2017)...  Caris Life Sciences ® , a leading innovator ... precision medicine, today announced that St. Jude Medical Center,s ... (POA) as its 17 th member. Through participation ... Cancer Institute will help develop standards of care and ... making cancer treatment more precise and effective. ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology:
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):